ARTICLE | Company News
Diosynth, HGSI manufacturing deal
June 10, 2004 7:00 AM UTC
Diosynth will manufacture monoclonal antibodies for Human Genome Sciences (HGSI) and is responsible for the technology transfer, scaling-up and production of the antibodies at its cell culture facilit...